Teoxane Teosyal® PureSense Ultra Deep is a professional hyaluronic acid filler designed for deep volumising and contour correction in areas of significant tissue loss. Its cohesive gel structure supports controlled projection while maintaining integration within surrounding tissues. Formulated with lidocaine for enhanced injection comfort, the product is suitable for clinicians seeking a reliable solution for advanced volume restoration. Supplied as prefilled syringes and manufactured to European medical-device standards, Teosyal PureSense Ultra Deep is intended for trained practitioners delivering deep structural aesthetic treatments.
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesTeosyal® PureSense Ultra Deep is a CE-marked hyaluronic acid dermal filler developed for deep tissue volumisation and structural support in areas requiring significant projection and contour restoration. Manufactured by Teoxane Laboratories, the product contains cross-linked hyaluronic acid of non-animal origin, formulated to maintain stability under dynamic facial movement while providing robust lifting capacity.
The inclusion of lidocaine hydrochloride (PureSense technology) is intended to improve patient comfort during injection. Teosyal PureSense Ultra Deep is characterised by a highly cohesive gel structure, supporting placement in deeper anatomical planes where mechanical strength and shape retention are required. The product is supplied in prefilled syringes and is intended for use exclusively by qualified medical professionals, in accordance with manufacturer guidance and applicable regulatory standards.
Teosyal® PureSense Ultra Deep belongs to the category of high-density hyaluronic acid dermal fillers designed for deep volumisation and contour support. Comparable products include Juvederm® Voluma and Restylane® Lyft, which similarly utilise cross-linked HA to restore volume in deeper tissue planes.
Compared with mid-dermal fillers or skin-boosting injectables such as Profhilo®, Ultra Deep is formulated specifically for structural correction rather than skin hydration or bio-remodelling. Its gel characteristics are optimised for projection and shape retention rather than superficial tissue integration. Longevity across this category varies depending on HA cross-linking technology, injection depth, anatomical area, and patient-specific metabolic factors.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Deep facial volume loss
Structural contour correction
Specific anatomical sites are not detailed in publicly available IFU documentation.
Only parameters explicitly supported by manufacturer or IFU-level documentation are listed.
Injection depth: not provided by manufacturer
Volume per injection point: not provided by manufacturer
Needle gauge: not provided by manufacturer
Frequency / number of sessions: not provided by manufacturer
Professional-use disclaimer:
Administered only by qualified medical professionals under aseptic conditions.
Some practitioners apply region-specific deep-plane techniques; these are not included in the manufacturer’s official IFU.
Cross-linked hyaluronic acid (non-animal origin) — concentration not provided by manufacturer
Lidocaine hydrochloride — percentage not provided by manufacturer
Physiological buffer solution (excipients)
Packaging: 2 Ă— 1.2 ml prefilled syringes
Shelf life: not provided by manufacturer
Treatment duration: not provided by manufacturer
Contraindicated in patients with known hypersensitivity to hyaluronic acid, lidocaine, or any formulation component
Should not be used in the presence of active skin infection or inflammation at the injection site
Use with caution in patients with autoimmune conditions or a history of severe allergic reactions, in accordance with general HA filler precautions
CE-marked medical device for aesthetic use within the European market
Regulatory classification not specified in public documentation; verify on the product packaging or manufacturer’s IFU.
Teosyal PureSense Ultra Deep is intended for deep tissue volumisation and structural contour correction in cases of significant volume loss. It is formulated to provide mechanical support in deeper tissue planes rather than superficial skin improvement.
The product uses cross-linked hyaluronic acid to physically restore volume by occupying space within deep soft tissues. Its cohesive gel structure supports shape retention and resistance to deformation under facial movement.
Yes. The formulation includes lidocaine hydrochloride to support patient comfort during injection. The exact concentration is not specified in publicly available manufacturer documentation.
The manufacturer does not state a defined duration of effect. Longevity depends on multiple factors including injection depth, treatment area, patient metabolism, and volume used.
Ultra Deep is designed for deep structural support, whereas mid-dermal fillers focus on moderate volume correction or wrinkle smoothing. It is not intended for superficial skin hydration or bio-remodelling applications.
Let’s talk on WhatsApp